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Edited by Ulrike KutayAbstract We investigated the cellular localization of ectopi-
cally-expressed CIS, SOCS1, SOCS2 and SOCS3 proteins.
We found that SOCS proteins localize to the nucleus where they
reduce Stat3 proteins and that the presence of proteasome inhib-
itors increased SOCS nuclear localization. Our results indicate
that increased nuclear localization resulted from increased levels
of SOCS proteins in the cytoplasm. Finally, we demonstrate that
the same eﬀect occurs with endogenously-expressed SOCS pro-
teins. These observations suggest that increased cytoplasmic lev-
els of proteins in the SOCS family are regulated through nuclear
translocation.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Suppressors of cytokine signaling (SOCS) proteins are a
group of negative feedback regulators of the Janus kinase
(Jak)/signal transducer and activator of transcription (Stat),
or receptor tyrosine kinase pathways [1,2]. SOCS proteins
are involved in inhibiting a large variety of stimulatory pro-
teins, including insulin, interleukin-2 (IL-2), IL-3, prolactin,
growth hormone (GH), and erythropoietin [1,3]. The SOCS
family of proteins consists of eight members, cytokine-induc-
ible SH2-containing protein (CIS) and SOCS1-7 [1,4]. These
proteins are composed of three structural domains: a SOCS
box, a cytokine-inducible Src homology 2 domain protein
(SH2) domain, and a N-terminal region of variable length
[4,5]. SOCS members can be divided into two groups basedAbbreviations: SOCS, suppressors of cytokine signaling; Stat, signal
transducer and activator of transcription; Jak, Janus kinase; SH2,
cytokine-inducible Src homology 2 domain protein; CIS, cytokine-
inducible SH2-containing protein
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doi:10.1016/j.febslet.2008.05.039on the length of their N-terminal region. SOCS4-7 are each
composed of a long N-terminal region of over 200 amino
acids, whereas CIS and SOCS1–3 have a short N-terminal re-
gion of less than 50 amino acids [4,5]. SOCS proteins with a
short N-terminal domain have been extensively studied, and
are disease-associated [6–9].
Studies of SOCS proteins show that the factors they interact
with and regulate are primarily located in the cytoplasm. For
example, they interact with the Jak, Stat, or other receptor
tyrosine kinases via their SH2 domain in order to block signal-
ing [2,10]. SOCS proteins also interact with E3 ubiquitin ligase,
which is involved in proteasome-mediated degradation of pro-
teins [11,12]. However, recent studies showed that SOCS mem-
bers with a long N-terminal region localize to the nucleus. For
example, SOCS6 localizes to the nucleus where it reduces Stat3
[13]. Furthermore, SOCS7 is a shuttling protein that transports
cytoplasmic proteins into the nucleus and contributes to cell
cycle arrest [14].
In the present study, we investigated whether SOCS proteins
with a short N-terminal region localize to the nucleus. We
found that overexpressed SOCS proteins localize to the nu-
cleus where they reduce the Stat3 protein. Moreover, we found
that SOCS proteins localize to the nucleus when their levels in-
crease. These results suggest that SOCS proteins are regulated
by translocation from the cytoplasm to the nucleus under cer-
tain biological conditions.2. Materials and methods
2.1. Reagents
Antibodies against hSnf2H, HA tag and Lamin B1 were purchased
from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-b-actin and
anti-Flag tag antibodies were purchased from Sigma (St. Louis,
MO). Antibodies against SOCS2 and SOCS3 were obtained from Ab-
cam (Cambridge, UK). The antibody against SOCS1 was from Zymed
(South San Francisco, CA). The proteasome inhibitors MG132 and
Epoxomicin were purchased from Calbiochem (La Jolla, CA).
2.2. Cell culture
HEK293T, HeLa, and U87MG (ATCC, Manassas, VA) were cul-
tured using DMEM or RPMI1640, containing 10% fetal bovine serum,
100 U/ml penicillin, and 100 lg/ml streptomycin (WelGENE, Seoul,
Korea).
2.3. Plasmids and transfection
Plasmids pl-Pkcd, pl-Erk1, and Jnk1 [15] were received from Dr.
Gang Min Hur at Chungnam University, Korea. The pEF-Flag-CIS,
pEF-Flag-SOCS1, pEF-Flag-SOCS2, pEF-Flag-SOCS3, PKBa, and
Stat3-C plasmids have been described previously [16–18].blished by Elsevier B.V. All rights reserved.
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30% conﬂuence, and were grown for 20 h. Cells were transiently trans-
fected according to the manufacturers instructions (WelGENE), as
previously described [13].
2.4. Isolation of cytoplasmic and nuclear protein extracts
The nuclear and cytoplasmic extraction kit (Pierce, Rockford, IL)
was used to isolate the respective fractions according to the manufac-
turers instructions, as previously described [13].
2.5. Immunocytochemistry
HeLa cells were plated onto chamber slides 16 h prior to transfec-
tion. They were then transiently transfected with SOCS expression vec-
tors and incubated for 24 h, ﬁxed for 10 min with 4%
paraformaldehyde, and permeabilized for 20 min at room temperature
in PBS containing Triton X-100 and BSA. They were incubated with
anti-Flag tag primary antibody overnight at 4 C. Incubation with
FITC-conjugated secondary antibody (Zymed) and DAPI were per-
formed for 1 h at 37 C. To visualize endogenous SOCS3, U87MG
cells were incubated with anti-SOCS3 primary antibody (Zymed) fol-
lowed by a ﬂuorescently-labeled secondary antibody (Alexa Fluor
568, Molecular Probes, Invitrogen, Carlsbad, CA). The stained cells
were then subsequently examined with an inverted ﬂuorescence micro-
scope [13].Fig. 2. Overexpressed SOCS proteins are detected in the nucleus and
reduce the levels of activated Stat3 in HEK293T cells. (A) Plasmids
encoding Flag-CIS, Flag-SOCS1, Flag-SOCS2, and Flag-SOCS3 were
transfected into HEK293T and cytoplasmic (Cy) and nuclear (Nu)
protein extracts were prepared 25 h after transfection. Western-blot
analysis was then performed using antibodies against Flag, hSnf2H,
and b-actin. (B, C) Plasmids encoding Flag-Stat3-C, the activated form
of Stat3, were co-transfected with Flag-CIS, Flag-SOCS1, Flag-
SOCS2, and Flag-SOCS3 plasmids or the empty vector (Empty+-
Stat3-C), and Cy and Nu protein extracts were prepared at 25 hrs
(lanes 1, 3, and 5) or 40 h (lanes 2, 4, and 6) after transfection.
Western-blot analysis was then performed using antibodies against
Flag, hSnf2H, and b-actin.3. Results
3.1. Overexpressed CIS, SOCS1, SOCS2, and SOCS3 proteins
primarily localize to the nucleus in HeLa cells
To investigate the cellular location of SOCS proteins with
short N-termini, we transfected plasmids encoding Flag-CIS,
Flag-SOCS1, Flag-SOCS2, and Flag-SOCS3 into HeLa cells,
and observed the localization of proteins by immunocyto-
chemical analysis. Transfected SOCS1, SOCS2, and SOCS3
proteins localized to the nucleus, while the CIS proteins were
distributed both in the cytoplasm and nucleus (Fig. 1A–D).
3.2. Overexpressed SOCS proteins localize to the nucleus where
they reduce Stat3
Next, we examined the levels of SOCS proteins in the nu-
cleus and cytoplasm using Western-blot analysis. We transfec-
ted plasmids encoding Flag-CIS, Flag-SOCS1, Flag-SOCS2,
and Flag-SOCS3 into HEK293T cells to conﬁrm the localiza-
tion of the SOCS proteins in a cell line other than HeLa. Cyto-Fig. 1. Overexpressed CIS, SOCS1, SOCS2, and SOCS3 proteins are primar
CIS, (B) Flag-SOCS1, (C) Flag-SOCS2, and (D) Flag-SOCS3 were transfecte
the respective proteins (green) is shown in the left panels, and DAPI nucleaplasmic and nuclear protein extracts were isolated, and
localization of CIS, SOCS1, SOCS2, and SOCS3 was observed
using anti-Flag antibodies. As a control, we used the hSnf2H
protein, which is a subunit of the SWI/SNF co-activator com-
plex required for transcription and is primarily located in theily localized in the nucleus of HeLa cells. Plasmids encoding (A) Flag-
d into HeLa cells and analyzed by immunocytochemistry. Staining for
r staining (blue) is shown in the right panels.
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and the nucleus, served as a loading control. We detected both
nuclear and cytoplasmic localization of the transfected plas-
mids encoding SOCS proteins (Fig. 2A). Each SOCS protein
showed diﬀerential distribution between cytoplasm and nu-
cleus. SOCS1 and SOCS3 had higher levels of nuclear localiza-
tion than did CIS and SOCS2 (Fig. 2A).
SOCS proteins negatively regulate Stat3 activity to prevent
continuous activation [1,2]. We sought to determine if over-
expressing activated Stat3 with the SOCS proteins changed
Stat3 protein levels in a manner that was dependent on SOCS
localization. Co-transfection of a plasmid encoding Stat3-C,
the active form of Stat3, along with empty vector showed a
protein localization ratio that was similar between the cyto-
plasm and nucleus (lanes 1 and 2, Fig. 2B and C). When the
Stat3-C-encoding plasmid was co-transfected with the plas-
mids encoding the various SOCS proteins, SOCS1 and SOCS3
eﬀectively decreased Stat3 levels in both the nucleus and cyto-
plasm (lanes 3–6, Fig. 2B). However, we did not observe a
reduction of Stat3 in the nucleus for the CIS and SOCS2 co-
transfected cells, but were able to detect reduced cytoplasmic
Stat3 levels after 40 h (lanes 3–6, Fig. 2C). The results alsoFig. 3. Nuclear levels of SOCS proteins were increased by treatment with inhi
cells, cytoplasmic (C or Cy) or nuclear (N or Nu) extracts were prepared an
follows. Twenty hours after transfection of plasmids encoding (A) Flag-CIS
stimulated with 10 lM MG132 for 2, 4, and 8 h or left untreated (0) for 8 h.
PKBa, Pkcd or (F) Stat3-C, cells were stimulated with 10 lMMG132 (MG) fo
plasmids encoding (G) Flag-CIS, Flag-SOCS1, Flag-SOCS2, and Flag-SOCS
untreated (Con) for 4 h.indicate that SOCS1 and SOCS3 reduced Stat3 more eﬃciently
than did CIS and SOCS2 (lanes 1 and 2 vs. lanes 3–6, Fig. 2B
and C).
3.3. Nuclear SOCS protein levels are increased by the addition
of proteasome inhibitors
SOCS protein stability increases with proteasome inhibition
[11,12]. Therefore, we tested if localization of SOCS proteins
was altered by increased protein stability in the presence of
the proteasome inhibitor, MG132 [19]. After transfection of
plasmids encoding CIS, SOCS1, SOCS2, and SOCS3, we trea-
ted with MG132 for 2, 4, and 8 h. Levels of all of the SOCS
proteins increased maximally by 4 h (data not shown). We then
observed the cellular distribution of SOCS proteins. Levels of
CIS and SOCS2 increased in the nucleus only, while levels of
SOCS1 and SOCS3 proteins increased in both the cytoplasm
and nucleus (Fig. 3A–D). CIS and SOCS2 were not increased
in the cytoplasm, suggesting that localization of increased pro-
tein levels resulting from drug treatment was restricted to the
nucleus.
We tested if the levels of other overexpressed proteins can be
increased in the nucleus by MG132 treatment. After transfec-bitors of proteasome activity. Plasmids were transfected into HEK293T
d Western-blot analysis was performed on transfected cells treated as
, (B) Flag-SOCS1, (C) Flag-SOCS2, and (D) Flag-SOCS3, cells were
Twenty hours after transfection of plasmids encoding (E) Jnk1, Erk1,
r 4 h or left untreated (Con) for 4 h. Twenty hours after transfection of
3, cells were stimulated with 0.5 lM epoxomicin (Epoxo) for 4 h or left
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C, we treated with MG132 for 4 h and observed protein distri-
bution. As shown in Fig. 3E–F, not all of the proteins showed
increased levels in the nucleus after MG132 treatment. There-
fore, we concluded that the increase of proteins in the nucleus
by MG132 was restricted to SOCS proteins. We then examined
the nuclear localization of SOCS proteins after treatment with
another proteasome inhibitor, epoxomicin [19]. Epoxomicin
treatment for 4 h strongly increased nuclear protein levels of
CIS and SOCS2. In addition, the levels of SOCS1 and SOCS3
were slightly increased in the nucleus by drug treatment
(Fig. 3G). Altogether, we conclude that proteasome inhibitors
increased the nuclear localization of SOCS proteins.
3.4. SOCS proteins are localized to the nucleus when protein
levels are increased
Proteasome inhibitors may aﬀect other proteins that inﬂu-
ence the stability of SOCS proteins, and therefore, the eﬀect
could be indirect. We examined if increased nuclear localiza-
tion occurred for SOCS proteins in the absence of proteasome
inhibitors. We then identiﬁed two diﬀerent conditions for
increasing SOCS protein levels. First, CIS and SOCS2 protein
levels increased following transfection (data not shown). How-
ever, no increase in the levels of SOCS1 and SOCS3 occurred
under these conditions, suggesting that these proteins are reg-Fig. 4. SOCS proteins localized to the nucleus when protein levels are increa
Flag-SOCS3 were transfected into HEK293T. Cytoplasmic (Cy) and nuclear
Western-blot analysis was performed using antibodies against Flag, hSnf2
SOCS2, and Flag-SOCS3 were co-transfected with plasmids encoding Stat3
protein extracts were prepared, and Western-blot analysis was performed. (
encoding Stat3-C, cytoplasmic (Cy) and nuclear (Nu) protein extracts were p
transfected with same amount of plasmid DNA encoding Flag-CIS or Flag
plasmid DNA encoding Stat3-C than was used for lane 1.ulated diﬀerently from CIS and SOCS2. We then examined if
nuclear localization of SOCS proteins was observed under
the same conditions. Nuclear protein levels of CIS and SOCS2
increased later, at 40 h after transfection (Fig. 4A). Second,
protein levels of CIS, SOCS1, and SOCS2 increased when lev-
els of Stat3 protein increased (data not shown). The levels of
SOCS proteins may be increased or stabilized by a certain
mechanism in the presence of increased levels of the target
Stat3 protein. When we observed localization under these con-
ditions, nuclear localization was increased for CIS, SOCS1,
and SOCS2 (Fig. 4B). With increased amounts of transfected
plasmid encoding Stat3-C, CIS and SOCS2 protein levels in-
creased, results which translated into increased nuclear locali-
zation (compare lanes 1 and 2 in Fig. 4C and D). This
conﬁrmed that an increase in the levels of SOCS proteins stim-
ulated increased nuclear localization.
3.5. Proteasome inhibition increases the nuclear translocation of
endogenous SOCS proteins
As the experiments thus far were performed using transfec-
ted cells, we sought to detect increased levels of endogenous
SOCS proteins in the nucleus after proteasome inhibition. In
preliminary experiments, endogenous SOCS1, SOCS2, and
SOCS3 proteins were detected in U87MG cells (data not
shown). Therefore, we tested if MG132 or epoxomicin in-sed. (A) Plasmids encoding Flag-CIS, Flag-SOCS1, Flag-SOCS2, and
(Nu) protein extracts were prepared at 25 or 40 h after transfection and
H, and b-actin. (B) Plasmids encoding Flag-CIS, Flag-SOCS1, Flag-
-C, or with empty vector (Emp). Cytoplasmic (Cy) and nuclear (Nu)
C, D) Plasmids encoding Flag-CIS were co-transfected with plasmids
repared, and Western-blot analysis was performed. Lanes 1 and 2 were
-SOCS2, but lane 2 was transfected with a twofold higher amount of
Fig. 5. Proteasome inhibition increases nuclear translocation of endogenously expressed SOCS proteins. (A–D) U87MG cells were grown to 50%
conﬂuence, incubated for 24 h, and stimulated with 10 lMMG132 or 0.5 lM epoxomicin (Epoxo) for 2 or 5 h, or left untreated (0). Cytoplasmic (C)
and nuclear (N) protein extracts were prepared and Western-blot analysis was then performed using antibodies against SOCS3, SOCS1, SOCS2,
Lamin B1, and b-actin.
Fig. 6. Endogenously-expressed SOCS3 levels increased in the nucleus
with proteasome inhibition. U87MG cells were grown to 50%
conﬂuence and stimulated with 0.5 lM epoxomicin or 10 lM
MG132 for 5 h. Untreated cells served as control. Immunocytochem-
ical staining for SOCS3 is indicated by red ﬂuorescence.
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cells. We used Lamin B1 for the nuclear loading controls, since
we did not detect hSnf2H protein in U87MG cells (data not
shown). Both drugs increased endogeneous levels of SOCS1
and SOCS3 in the nucleus (Fig. 5A–C), but not SOCS2. These
results show that increased nuclear localization of SOCS1 and
SOCS3 proteins occurred endogenously. To conﬁrm the re-
sults, we observed endogenous SOCS3 in U87MG cells by
immunocytochemical staining. SOCS3 translocated to the nu-
cleus following treatment with epoxomicin or MG132 (Fig. 6).4. Discussion
The most important ﬁndings of this study are that CIS,
SOCS1, SOCS2, and SOCS3 localize to the nucleus, and that
localization was regulated by cellular conditions. We observedthat localization patterns diﬀered between cell types, and that
nuclear localization was stimulated by conditions that in-
creased cytoplasmic protein levels. We predict that a transport
protein interacts with SOCS proteins to bring them into the
nucleus.
Each SOCS protein exhibited a unique cellular behavior,
compared to previous observations. We observed that the
localization of SOCS1 and SOCS3 was diﬀerently regulated
from that of CIS and SOCS2. Functionally, SOCS1 and
SOCS3 eﬀectively decreased Stat3 levels throughout the cell,
whereas CIS and SOCS2 did not. Therefore, we propose that
the cellular localization of SOCS members is closely coordi-
nated with biological function. Although SOCS proteins con-
tain conserved domains, the localization and function seem
to be diﬀerently regulated. It would be interesting to further
investigate the domains or regions that may determine diﬀerent
functions based on localization.
Previous reports show that SOCS protein levels were in-
creased after proteasome inhibition [11,12]. Our Western-blot
analysis results showed that the increase in SOCS protein levels
correlated with increased nuclear protein levels. With immuno-
cytochemical staining, we demonstrated the concentration of
SOCS protein in nucleus as a result of proteasome inhibition.
It is possible that an increase in the level of SOCS proteins in
the cytoplasm resulted in translocation into the nucleus. Fur-
thermore, a regulatory mechanism might sense the amount
of SOCS proteins in the cytoplasm. We propose that once
SOCS proteins are increased to maximum levels in the cyto-
plasm, the proteins are then transported into nucleus, perhaps
by importins. It would be of interest to further investigate the
speciﬁc proteins involved in the translocation of SOCS pro-
teins.
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